AHK-Cu: hair-follicle experiments and evidence limits
AHK-Cu is a copper complex of the tripeptide alanine–histidine–lysine. Its best-matched source in the reviewed record is a laboratory study of isolated human hair follicles and dermal papilla cells. Human-derived tissue is useful, but it is not evidence that a cosmetic or injectable product regrows hair in patients.
Identity and formulation
AHK-Cu contains alanine as its first amino acid. GHK-Cu begins with glycine, and plain AHK does not designate the same copper complex.
A finished scalp product has its own concentration, vehicle and delivery properties. Those features cannot be inferred from a study that directly exposes cultured follicles or cells to a test substance.
What the studies show
The 2007 study found follicle elongation and cellular responses under experimental conditions. It did not enroll patients for a controlled hair-count trial, compare treatments for a diagnosed hair-loss disorder or measure a durable cosmetic result after stopping treatment.
| Study and design | Finding | What it does not establish |
|---|---|---|
| The effect of tripeptide-copper complex on human hair growth in vitro.
Ex vivo human hair follicles and cultured human dermal papilla cells Reading scope: PubMed abstract and bibliographic record; not full-text review |
AHK-Cu stimulated follicle elongation and dermal papilla cell proliferation under the tested conditions. | These were laboratory endpoints. The reported decrease in apoptotic cells was not statistically significant and should not be promoted as a proven anti-apoptotic clinical effect. |
For the differences between a mechanism, a biomarker and a clinical outcome, see the evidence-reading guide.
How to interpret the findings
A follicle kept in culture bypasses delivery through intact skin and many features of an ongoing hair-loss disorder. A positive elongation result therefore establishes a hypothesis, not a predicted number of new hairs.
Useful next studies would define the finished formulation and compare standardized hair counts or density against a matched vehicle in a diagnosed population, with adverse events and follow-up reported.
Safety context
The laboratory evidence does not establish long-term scalp tolerability, rare reactions or safety of systemic administration. Copper-related identity testing is also separate from those clinical questions.
Study exposure and units
Culture concentrations should retain their laboratory units and exposure conditions. They do not supply a topical percentage, frequency or injection regimen for people.
A commercial product concentration is not the concentration that reaches a living follicle. Delivery, stability and the vehicle require their own evidence.
Match any reported amount or concentration to the exact material, route, population and duration in the original experiment. Read the guide to mass, volume and concentration for the meaning of common units. A calculation cannot establish an appropriate treatment or validate an untested formulation.
Product identity and report checks
Verify the AHK sequence, copper complex and the analytical method used to characterize them. A report for GHK-Cu or copper salt alone does not confirm AHK-Cu identity.
For a topical formulation, distinguish the amount of complex from the total serum quantity. A supplier certificate does not turn the isolated-follicle result into a clinical hair-regrowth claim.
Keep the clinical evidence and the supplier evidence separate. Use the report-verification steps to check the issuer and the batch questions to connect a tested sample with the product offered. Compare prices using the delivered-cost method rather than an isolated discount or purity percentage.
Peptide Serum operates a store as well as this research library. The supplier directory contains imported seller information; a listing is not laboratory certification. Read how this library is prepared and evaluate the documentation for the exact lot offered. A seller rating does not establish clinical safety or effectiveness.
Common questions
Was AHK-Cu tested in humans?
The cited experiment used tissue and cells obtained from humans. It was not a trial in which people used the product and had hair growth measured. That distinction should appear in every summary.
Can GHK-Cu studies fill the gaps?
Only as clearly labeled related research. Changing the first amino acid changes the peptide, and copper complexation also matters. Evidence cannot silently transfer between the names.
Sources
- The effect of tripeptide-copper complex on human hair growth in vitro. (PubMed abstract and bibliographic record; not full-text review)